New Technology Could Be Key To Developing Malaria Vaccine

Quartz Africa: African scientists are closer than ever to developing a malaria vaccine
Faith Osier, immunologist at the Wellcome Trust

“…As an immunologist, I dream that one day we will have an effective vaccine that will help eliminate malaria. … In experiments conducted over 50 years ago, researchers showed that blood could be taken from adults who had become immune and used to treat children admitted to hospital with malaria. Antibodies in the blood were responsible for this effect; in other words, antibodies could treat malaria. Researchers have been trying to isolate the exact antibodies that do this. … Developments in technology now mean that it’s possible to do this much more efficiently. And we’re really excited that we have been able to exploit these new innovations in Africa. … I believe the key to making a better malaria vaccine is right here with us. With patience, perseverance, and continued hard work, we will find the recipe required to make a really good malaria vaccine” (11/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.